Benchling Case Study Anthology: Pushing the Frontier of Life Science Innovation

From next-generation cell therapies, to CRISPR-based gene therapies, to biologically-derived materials, life science R&D has never been more complex or more varied. But despite the explosion in scientific techniques and applications, modern life science companies have one challenge in common: taming the complexity of their data.

Paper notebooks, spreadsheets, and legacy software like ELNs and LIMS can’t handle the complexity of modern life science. They slow down R&D progress, scatter data across silos, and wipe out institutional knowledge. Companies need a solution that’s built for modern life science to track, interlink, and analyze the vast amounts of data their R&D programs are producing.

Benchling has helped over 350 companies across life science centralize and standardize their R&D data to drive better decisions and accelerate the pace of innovation. In this anthology, we’ve brought together stories about how some of our most cutting-edge customers transformed their R&D with Benchling.

Read this anthology to hear R&D leaders share the following stories and videos:

  • Adicet Bio: Building a Data Infrastructure for Next-Generation Cell Therapies (Includes Video )
  • Agenus: Building a Global Informatics Infrastructure (Includes Video )
  • Bolt Threads: Optimizing Biomaterials R&D with Data-Driven Insights (Includes Video )
  • Rubius Therapeutics: Optimizing Cell Engineering with a Unified Informatics Platform (Includes Video )
  • Synlogic: Accelerating Synthetic Biology with Fully Unified Informatics (Includes Video )
  • Arcturus: Enhancing Research Productivity by 30%
  • Zymergen: Integrating the Custom Solutions of a Technology Powerhouse
  • Obsidian Therapeutics: Unlocking Pivotal R&D Answers While Ensuring Data Integrity (Includes Video )
  • Incyte: Structuring World-Class Informatics for a New Team
  • Inhibrx: Centralizing Biologics Data for a Growing Company
  • Intellia: Streamlining Registration and Requests for Gene Editing

Read the Case Study Anthology

 

BY ROGER PELLEGRINI
July 22, 2020